← FDA Drug Approvals (Drugs@FDA)
APOMORPHINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2022-02-23
Drug application
- FDA Application #
ANDA212025- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- APOMORPHINE HYDROCHLORIDE
- Generic name
- APOMORPHINE HYDROCHLORIDE
- Active ingredients
- APOMORPHINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- TP ANDA HOLDINGS
- Manufacturer
- TruPharma, LLC
- First approval
- 2022-02-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown